Is PHIO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHIO. It does not provide personalized investment advice.

PHIO (Phio Pharmaceuticals Corp. Common Stock) Stock Analysis - Financials

Phio Pharmaceuticals Corp. Common Stock (PHIO) is a publicly traded Healthcare sector company. As of September 11, 2026, PHIO trades at $1.04 with a market cap of $11.97M and a P/E ratio of -0.70. PHIO moved +0.00% today. Year to date, PHIO is -7.34%; over the trailing twelve months it is -59.11%. Its 52-week range spans $0.81 to $4.19. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces PHIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are PHIO's key financials?

PHIO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHIO recently traded at $1.04. Market cap is $11.97M. P/E ratio is -0.70. Revenue is $0.

PHIO Key Metrics

Key financial metrics for PHIO
Metric	Value
Price	$1.04
Market Cap	$11.97M
P/E Ratio	-0.70
EPS	$-1.45
Dividend Yield	0.00%
52-Week High	$4.19
52-Week Low	$0.81
Volume	10.25K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-8.70M
Gross Margin	0.00%

PHIO Analyst Consensus

1 analysts cover PHIO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.

Common questions about PHIO

What are PHIO's key financials?: PHIO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PHIO recently traded at $1.04. Market cap is $11.97M. P/E ratio is -0.70. Revenue is $0.
Is PHIO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHIO. It does not provide personalized investment advice.